Expert compilation, review, and remediation of UK MDR 2002 (as amended) Technical Documentation. Ensure your dossier is audit-ready for Approved Body submission
Medical device manufacturers placing products on the GB (Great Britain) market must prepare and maintain comprehensive technical documentation to demonstrate compliance with the UK Medical Device Regulations 2002 (as amended).
A UKCA Marking Technical File is a core regulatory requirement for medical devices and provides the documented evidence needed to demonstrate that a device meets the applicable Essential Requirements (ERs).
Patient Guard provides expert UKCA Marking Technical File services for medical device manufacturers, supporting the preparation, review, remediation, and ongoing maintenance of UK MDR-compliant technical documentation.
We help manufacturers develop structured, audit-ready Technical Files that demonstrate conformity with the applicable Essential Requirements of the UK Medical Devices Regulations 2002 (as amended), supporting UK Approved Body assessment where required.
Whether you are preparing a new Technical File, updating legacy documentation, or addressing identified gaps, we ensure a clear and compliant route to UKCA marking readiness.
This page explains Patient Guard’s UKCA Technical Documentation services, helping manufacturers prepare compliant technical files for placing medical devices on the Great Britain market. If you're looking for a broader introduction to UK medical device regulations, including UKCA marking, MHRA registration, UK Responsible Person requirements, technical documentation, conformity assessment and post-market surveillance, read our Complete Guide to Regulating Medical Devices in the UK.
We specialise in medical device technical documentation and regulatory compliance.
We support manufacturers across a wide range of medical device technologies and classifications.
We align your technical documentation with UK MDR and Approved Body expectations.
We support all aspects of technical file preparation and remediation.
We prepare documentation suitable for UKCA conformity assessment and inspection.
Clear project-based pricing with no hidden costs.
We prepare structured technical documentation aligned with UK MDR requirements.
We support intended use, device description, variants, and specification development.
We prepare or review ISO 14971 risk management documentation and reports.
We support Clinical Evaluation Reports (CERs) and clinical evidence integration.
We support performance testing, usability, software validation, and biocompatibility evidence.
We ensure labels and Instructions for Use meet UK regulatory expectations.
We align technical documentation with PMS, PMCF, and vigilance processes.
We identify and remediate deficiencies within existing technical files.
Under UK MDR 2002, manufacturers must maintain technical documentation covering:
| Technical File Element | Our Support & Scope |
|---|---|
| Technical file structure and development | We prepare structured technical documentation aligned with UK MDR requirements. |
| Device description and specification documentation | We support intended use, device description, variants, and specification development. |
| Risk management documentation | We prepare or review ISO 14971 risk management documentation and reports. |
| Clinical evaluation support | We support Clinical Evaluation Reports (CERs) and clinical evidence integration. |
| Verification and validation documentation | We support performance testing, usability, software validation, and biocompatibility evidence. |
| Labelling and IFU review | We ensure labels and Instructions for Use meet UK regulatory expectations. |
| PMS and vigilance integration | We align technical documentation with PMS, PMCF, and vigilance processes. |
| Gap analysis and remediation | We identify and remediate deficiencies within existing technical files. |
We assess your device classification, intended use, and existing documentation to define the technical file strategy
We prepare and compile technical documentation, including risk management, clinical evidence, labelling, and validation records
We perform final compliance review and align documentation with UKCA and Approved Body expectations
We support Technical File preparation for a wide range of medical devices, including:
From
Ensure regulatory compliance and market readiness with expertly prepared UKCA Marking Medical Device Technical Files. Pricing starts from £6,000, with preferential rates for multiple products.
Assessment of your device and existing documentation against UK MDR requirements.
Compilation, structuring, and correction of documentation including ERs, risk management, and clinical data.
Final compliance check and preparation for UK Approved Body review, where applicable, or placement on the Great Britain market
Fast turnaround: most Technical Files are delivered within 4–8 weeks, subject to completeness of product information.
A UKCA technical file is the documentation demonstrating that a medical device complies with UK MDR requirements and can legally be placed on the Great Britain market.
Yes, technical documentation is a mandatory requirement under UK MDR 2002.
Typical contents include device descriptions, risk management, clinical evidence, validation data, PMS documentation, labelling, and declarations of conformity.
Yes, we provide technical file review, remediation, and gap assessment services.
Yes, SaMD and digital health devices require compliant technical documentation and validation evidence.
Click on the links below to discover more:
Planning to place a medical device on the US market? This complete guide explains FDA medical device regulations, including device classification, 510(k), De Novo and PMA pathways, QMSR and ISO 13485, establishment registration, device listing, U.S. Agent requirements, UDI and post-market obligations.
Preparing to sell digital health technology to the NHS requires more than completing DTAC. This guide explains how manufacturers can build a procurement-ready position by aligning regulatory compliance, clinical safety, data protection, cybersecurity, interoperability, accessibility and commercial evidence for NHS market access.
For digital health manufacturers preparing to enter the NHS, clinical safety can be one of the most important—and sometimes misunderstood—parts of DTAC.
It is not enough to demonstrate that your software works.
Manufacturers need to consider what could happen if the technology fails, produces incorrect information, presents information incorrectly, contributes to a workflow error or is used in circumstances that could expose patients to harm.
This is where clinical risk management and DCB0129 become particularly important.
NHS England identifies DCB0129 as the clinical risk management standard for manufacturers of health IT systems. Its counterpart, DCB0160, applies to health organisations deploying and using health IT systems. NHS England states that compliance with these standards is required under the Health and Social Care Act 2012.
For manufacturers working towards NHS DTAC readiness, understanding the distinction—and having the right clinical safety evidence—is essential.
If your digital health technology is heading towards the NHS, understanding the Digital Technology Assessment Criteria (DTAC) should be part of your market-access planning.
But one of the biggest mistakes manufacturers can make is treating DTAC as simply another questionnaire to complete.
The questions are only part of the process.
Behind your answers needs to be evidence showing that your technology and organisation have appropriate arrangements for clinical safety, data protection, technical security, interoperability, and usability and accessibility.
These five areas form the core of NHS DTAC. NHS England describes DTAC as national baseline criteria for digital health technologies entering NHS and social care.
For digital health manufacturers, the practical question is therefore not simply:
“Can we complete the DTAC assessment?”
It is:
“Can we demonstrate that our product meets the requirements?”
This guide looks at each of the five DTAC areas, the types of evidence manufacturers should consider and some of the common gaps that can delay NHS readiness.
A complete guide to NHS DTAC compliance for digital health manufacturers, covering the five DTAC assessment areas, required evidence, clinical safety, data protection, technical security, interoperability and usability, and how to prepare your digital health technology for NHS procurement.
Before a cosmetic product can legally be placed on the UK market, manufacturers and Responsible Persons must demonstrate that it is safe for human use under normal or reasonably foreseeable conditions. The Cosmetic Product Safety Report (CPSR) is one of the most important regulatory documents required under the UK Cosmetics Regulation. This guide explains what a CPSR is, who can prepare one, what information it must contain, how it relates to the Product Information File (PIF) and how it supports legal cosmetic compliance.
Speak to one of our regulatory and compliance experts to arrange an obligation-free call. Our experienced team is ready to help you get your medical device to market.
UK Office
Thank you! The checklist is now ready to download.
